No, the PIP is not intended to permit personal importation of cheaper versions of FDA approved
drugs from Canada or other foreign countries. FDA cannot assure that foreign made
versions of FDA-approved drugs have been properly manufactured, are safe and
effective, and are exactly the same formulation as the FDA-approved versions. The PIP is
intended to make available, through the exercise of enforcement discretion, unapproved
drugs used to treat serious medical conditions for which no equivalent treatment exists in
the United States, and unapproved drugs used to continue treatment begun in a foreign
country.
